Paragon Capital Management (Colorado)’s Merck MRK Stock Holding History

Paragon Capital Management (Colorado)’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$523K	Sell	4,346 -491	-10%	-$56.7K	0.11%	73
2025 Q4	$509K	Buy	4,837 +12	+0.2%	+$1.13K	0.1%	74
2025 Q3	$405K	Buy	4,825 +12	+0.2%	+$988	0.08%	83
2025 Q2	$381K	Buy	4,813 +12	+0.2%	+$954	0.07%	92
2025 Q1	$431K	Buy	4,801 +510	+12%	+$47.6K	0.09%	83
2024 Q4	$427K	Buy	4,291 +8	+0.2%	+$825	0.09%	74
2024 Q3	$486K	Buy	4,283 +8	+0.2%	+$950	0.1%	67
2024 Q2	$529K	Sell	4,275 -571	-12%	-$73.6K	0.1%	60
2024 Q1	$639K	Buy	4,846 +8	+0.2%	+$986	0.11%	57
2023 Q4	$528K	Buy	4,838 +8	+0.2%	+$830	0.11%	61
2023 Q3	$497K	Buy	4,830 +6	+0.1%	+$647	0.11%	62
2023 Q2	$557K	Sell	4,824 -45	-0.9%	-$5.11K	0.12%	60
2023 Q1	$518K	Buy	4,869 +5	+0.1%	+$540	0.12%	66
2022 Q4	$540K	Buy	4,864 +6	+0.1%	+$613	0.14%	57
2022 Q3	$418K	Buy	4,858 +6	+0.1%	+$536	0.12%	59
2022 Q2	$442K	Sell	4,852 -2,786	-36%	-$247K	0.12%	61
2022 Q1	$627K	Buy	7,638 +99	+1%	+$7.8K	0.12%	56
2021 Q4	$578K	Sell	7,539 -25	-0.3%	-$1.99K	0.09%	64
2021 Q3	$568K	Sell	7,564 -364	-5%	-$27.7K	0.1%	63
2021 Q2	$617K	Buy	7,928 +1,515	+24%	+$113K	0.29%	43
2021 Q1	$472K	Buy	6,413 +7	+0.1%	+$516	0.24%	48
2020 Q4	$500K	Buy	6,406 +6	+0.1%	+$459	0.27%	44
2020 Q3	$507K	Buy	+6,400	New	+$501K	0.28%	42
2020 Q1	–	Sell	-6,802	Closed	-$590K	–	136
2019 Q4	$590K	Buy	6,802 +6	+0.1%	+$493	0.31%	41
2019 Q3	$546K	Sell	6,796 -578	-8%	-$46.3K	0.3%	41
2019 Q2	$590K	Buy	7,374 +6	+0.1%	+$459	0.34%	38
2019 Q1	$585K	Sell	7,368 -310	-4%	-$23.2K	0.35%	34
2018 Q4	$560K	Buy	7,678 +1	+0%	+$71	0.27%	35
2018 Q3	$520K	Sell	7,677 -465	-6%	-$29.6K	0.44%	44
2018 Q2	$472K	Buy	8,142 +1	+0%	+$56	0.42%	47
2018 Q1	$423K	Buy	+8,141	New	+$440K	0.19%	58
2017 Q4	–	Sell	-8,980	Closed	-$549K	–	209
2017 Q3	$549K	Sell	8,980 -634	-7%	-$38.4K	0.21%	58
2017 Q2	$588K	Sell	9,614 -415	-4%	-$25.3K	0.27%	40
2017 Q1	$608K	Buy	+10,029	New	+$608K	0.27%	41
2016 Q3	$273K	Hold	4,585	–	–	0.15%	66
2016 Q2	$252K	Hold	4,585	–	–	0.14%	66
2016 Q1	$231K	Hold	4,585	–	–	0.14%	64
2015 Q4	$231K	Hold	4,585	–	–	0.14%	68
2015 Q3	$216K	Sell	4,585 -105	-2%	-$5.58K	0.13%	71
2015 Q2	$255K	Hold	4,690	–	–	0.16%	63
2015 Q1	$257K	Hold	4,690	–	–	0.17%	61
2014 Q4	$254K	Sell	4,690 -209	-4%	-$11.6K	0.18%	58
2014 Q3	$277K	Hold	4,899	–	–	0.19%	59
2014 Q2	$270K	Hold	4,899	–	–	0.19%	62
2014 Q1	$265K	Hold	4,899	–	–	0.2%	56
2013 Q4	$234K	Hold	4,899	–	–	0.17%	55
2013 Q3	$223K	Sell	4,899 -839	-15%	-$38.3K	0.17%	60
2013 Q2	$254K	Buy	+5,738	New	+$256K	0.2%	56

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Paragon Capital Management (Colorado)'s MRK Position: Q1 2026 in Review

Paragon Capital Management (Colorado) reduced its Merck (MRK) stake by 10% in Q1 2026, selling an estimated $56.7K and leaving 4,346 shares worth $523K. The position accounts for 0.11% of the portfolio, ranked #73.

Paragon Capital Management (Colorado) first reported a position in MRK in Q2 2013 and has held it in 48 quarters since. The position peaked at $639K in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Paragon Capital Management (Colorado) held 4,346 shares of Merck worth $523K as of Q1 2026.
Paragon Capital Management (Colorado) sold 491 Merck shares in Q1 2026, an estimated $56.7K.
Merck made up 0.11% of Paragon Capital Management (Colorado)'s portfolio in Q1 2026, its #73 holding.
Paragon Capital Management (Colorado) first reported a position in Merck in Q2 2013 and has held it in 48 quarters since.
Paragon Capital Management (Colorado)'s Merck position peaked at $639K in Q1 2024.
3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Paragon Capital Management (Colorado)'s 13F filing for Q1 2026, filed 15 Apr 2026.